Drug Shortage Report for TRILEPTAL 600 MG
| Report ID | 128183 |
| Drug Identification Number | 02242069 |
| Brand name | TRILEPTAL 600 MG |
| Common or Proper name | TRILEPTAL FCT 600 MG 5 X 10 |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | OXCARBAZEPINE |
| Strength(s) | 600MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 5 X 10 |
| ATC code | N03AF |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2020-11-06 |
| Actual start date | |
| Estimated end date | 2020-11-16 |
| Actual end date | 2020-11-19 |
| Shortage status | Resolved |
| Updated date | 2020-11-20 |
| Company comments | Demand increase due to generic backorder. Limited stock available being allocated based on customer profile. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2020-11-20 | English | Compare |
| v4 | 2020-11-19 | French | Compare |
| v3 | 2020-11-19 | English | Compare |
| v2 | 2020-11-09 | French | Compare |
| v1 | 2020-11-09 | English | Compare |
Showing 1 to 5 of 5